CeriBell (CBLL) Stock Forecast: StockMap's 2-Week Call
CBLL stock forecast: StockMap's model makes no two-week call on CeriBell after the Nov 19 close: its evidence is split, 1 reasons for and 14 against. Right in 2 of 6 two-week windows on CBLL since Aug 21; by chance, a call on the same dates was right 60% of the time.
CeriBell last closed at $25.75, +0.47% on the session.
Against the IVW growth benchmark the position is +2.80% over the forecast window.
CeriBell's market cap is $1.00B as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -10 (too close to call).
Where CBLL sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 1 bullish and 14 bearish.
Agreement across those insights is 93%.
31 daily calls for CBLL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks CeriBell in the 17th percentile on return on equity, where 100 is best.
CeriBell is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks CeriBell as the 61st largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite CeriBell ranks 51st of 141 in the group, against a group median of -0.18.